User:Mr. Ibrahem/Saxagliptin

Saxagliptin, sold under the brand name Onglyza, is a medication used to treat type 2 diabetes. It is typically used either with metformin or when metformin is not tolerated. It is taken by mouth.

Common side effects include headache and urinary tract infection. Other side effects may include pancreatitis, joint pain, low blood sugar, and heart failure. While there is no evidence of harm in pregnancy, its use has not been well studied. It is in the dipeptidyl peptidase-4 (DPP-4) inhibitor class, which indirectly increases insulin when required.

Saxagliptin was approved for medical use in the United States and Europe in 2009. In the United Kingdom 4 weeks of treatment costs the NHS about £32 as of 2021. This amount in the United States costs about 400 USD. It is also available in combination with other medication including metformin or dapagliflozin.